文献速递重症综合管理与镇静镇痛

临床表型在ICU高龄患者限制生命维持治疗决策中的作用

The role of clinical phenotypes in decisions to limit life-sustaining treatment for very old patients in the ICU.
PubMed 文献 · Ann Intensive Care · 2023-05-10
一句话结论VIP2研究事后分析显示,ICU入院时临床表型可预测高龄患者限制生命维持治疗决策,联合表型、通气支持和国家预测效能最佳。

该研究为VIP2前瞻性观察研究的事后分析,纳入22个国家ICU中80岁及以上患者,通过聚类分析入院特征识别出7种表型,分析1268例患者表型与限制生命维持治疗决策的关系。结果显示,决定不启动和撤除生命维持治疗的发生率分别为26.5%和8.1%;以老年特征突出为特点的两种表型及代表最年长、危重程度低的表型,不启动治疗决策的比值比最高; Logistic回归模型以表型、通气支持和国家为自变量时,预测限制生命维持治疗决策的区分效能最佳。作者认为,入院临床表型可预测限制生命维持治疗决策,受文化规范(国家)影响,可指导进一步研究决策中的偏倚和偏好。

要点

  • 在22个国家ICU的80岁及以上患者中,决定不启动和撤除生命维持治疗的发生率分别为26.5%和8.1%。
  • 以老年特征突出为特点的两种表型及代表最年长、危重程度低的表型,不启动治疗决策的比值比最高。
  • Logistic回归模型以表型、通气支持和国家为自变量时,预测限制生命维持治疗决策的区分效能最佳。
  • 临床表型在文化规范(国家)背景下可预测限制生命维持治疗决策,作者认为可指导进一步研究决策中的偏倚和偏好。

适用人群与场景

  • VIP2研究纳入22个国家ICU中年龄80岁或以上的患者,本分析限于被分配到7种表型之一的1268例患者。

研究设计与关键结果

  • 研究类型为VIP2前瞻性观察研究的事后分析,纳入22个国家ICU中80岁及以上患者,通过聚类分析入院特征识别7种表型,分析1268例患者的限制生命维持治疗决策。
  • 决定不启动生命维持治疗的发生率为26.5%,撤除生命维持治疗的发生率为8.1%。
  • 以老年特征突出为特点的两种表型及代表最年长、危重程度低的表型,不启动治疗决策的比值比最高。
  • Logistic回归模型以表型、通气支持和国家为自变量时,预测限制生命维持治疗决策的区分效能最佳。

证据类型、等级与局限

  • 证据类型:前瞻性观察研究(VIP2)的事后分析。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为,入院临床表型可预测限制生命维持治疗决策,受文化规范(国家)影响,可指导进一步研究决策中的偏倚和偏好。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

BACKGROUND: Limiting life-sustaining treatment (LST) in the intensive care unit (ICU) by withholding or withdrawing interventional therapies is considered appropriate if there is no expectation of beneficial outcome. Prognostication for very old patients is challenging due to the substantial biological and functional heterogeneity in that group. We have previously identified seven phenotypes in that cohort with distinct patterns of acute and geriatric characteristics. This study investigates the relationship between these phenotypes and decisions to limit LST in the ICU.

METHODS: This study is a post hoc analysis of the prospective observational VIP2 study in patients aged 80 years or older admitted to ICUs in 22 countries. The VIP2 study documented demographic, acute and geriatric characteristics as well as organ support and decisions to limit LST in the ICU. Phenotypes were identified by clustering analysis of admission characteristics. Patients who were assigned to one of seven phenotypes (n = 1268) were analysed with regard to limitations of LST.

RESULTS: The incidence of decisions to withhold or withdraw LST was 26.5% and 8.1%, respectively. The two phenotypes describing patients with prominent geriatric features and a phenotype representing the oldest old patients with low severity of the critical condition had the largest odds for withholding decisions. The discriminatory performance of logistic regression models in predicting limitations of LST after admission to the ICU was the best after combining phenotype, ventilatory support and country as independent variables.

CONCLUSIONS: Clinical phenotypes on ICU admission predict limitations of LST in the context of cultural norms (country). These findings can guide further research into biases and preferences involved in the decision-making about LST. Trial registration Clinical Trials NCT03370692 registered on 12 December 2017.

来源:Ann Intensive Care,查看原文。版权归原作者所有。

参考来源

  1. Mousai O, Tafoureau L, Yovell T, et al. The role of clinical phenotypes in decisions to limit life-sustaining treatment for very old patients in the ICU. Ann Intensive Care. 2023. PMID: 37162595. doi:10.1186/s13613-023-01136-7

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。